Masimo Corporation (MASI) 59.14 $MASI Thermo Fisher

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 9:19 AM

Masimo Corporation (MASI) 59.14 $MASI

Thermo Fisher Closes FEI Deal, Grows in Electron Microscopy
Zacks Equity Research - Zacks Investment Research - 1 hr 37 mins ago
Thermo Fisher Scientific, Inc. (TMO) recently completed its earlier announced mega $4.2 billion acquisition of FEI Company.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), TMO: 152.19 (unch), IDXX: 112.68 (unch)

51.3% Return Seen to Date on SmarTrend Masimo Call (MASI)
Comtex SmarTrend(R) - Thu Sep 01, 12:18AM CDT
SmarTrend identified an Uptrend for Masimo (NASDAQ:MASI) on February 26th, 2016 at $39.09. In approximately 6 months, Masimo has returned 51.29% as of today's recent price of $59.14.
MASI: 59.14 (+0.15)

Inogen Hits 52-Week High on Solid Q2 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:01AM CDT
Share price of Inogen Inc (INGN) rallied to a new 52-week high of $59 on Aug 30, eventually closing a tad bit lower at $58.46.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), INGN: 58.02 (unch), NUVA: 65.47 (unch)

Veeva Systems (VEEV) Q2 Earnings, Revenues Top; View Up
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:57AM CDT
Veeva Systems (VEEV) reported adjusted earnings of 15 cents per share in the second-quarter fiscal 2017, a 20.9% increase on a year-over-year basis.
VEEV: 41.25 (+0.33), BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), NUVA: 65.47 (unch)

Varian Medical Excels on Growing International Footprint
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:46AM CDT
Varian recently announced the installation of a Clinac iX medical linear accelerator at Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia.
MASI: 59.14 (+0.15), VAR: 96.13 (unch), QDEL: 21.77 (+0.03), IDXX: 112.68 (unch)

PetMed Remains Strong on New Order Sales; Reorder Dips
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:44AM CDT
On Aug 29, 2016, we issued an updated research report on PetMed Express (PETS). This nationwide pet pharmacy presently carries a Zacks Rank #2 (Buy).
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), PETS: 20.16 (-0.21), IDXX: 112.68 (unch)

Varian Medical Hits 52 week High, Oncology Prospects Bright
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:56AM CDT
Share price of Varian Medical rallied to a new 52-week high of $96.31 on Aug 29.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), VAR: 96.13 (unch), IDXX: 112.68 (unch)

BioTelemetry Gets CE Mark for Holter Monitoring Software
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:38AM CDT
BioTelemetry (BEAT) recently announced the receipt of CE mark for its Holter analysis software.
MASI: 59.14 (+0.15), BEAT: 18.47 (-0.51), QDEL: 21.77 (+0.03), NUVA: 65.47 (unch)

Luminex Poised on Pipeline Strength, System Sales Upbeat
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:19AM CDT
Austin-based Luminex (LMNX) is well poised on pipeline strength and solid system sales.
MASI: 59.14 (+0.15), QDEL: 21.77 (+0.03), LMNX: 21.07 (unch), NUVA: 65.47 (unch)

Masimo Announces Four-Year Partnership with World Federation of Societies of Anaesthesiologists (WFSA)
BusinessWire - Mon Aug 29, 6:06PM CDT
Masimo (NASDAQ: MASI) announced Sunday at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World Federation of Societies of Anaesthesiologists (WFSA). The four-year partnership, "Safe Anaesthesia - ASAP" (Anesthesia Safety Action Plan), will initially identify one country with poor access to safe anesthesia, and will work toward implementing programs and training designed to improve anesthesia care and safe surgery outcomes.
MASI: 59.14 (+0.15)

INC Research Upgraded to Strong Buy on Estimate Revision
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:26AM CDT
On Aug 27, Zacks Investment Research raised INC Research Holdings Inc. (INCR) to a Zacks Rank #1 (Strong Buy).
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), ABCO: 42.15 (-0.04), INCR: 43.63 (-0.74)

Masimo Announces a Special Worldwide Program for Total Hemoglobin (SpHb(R)) Monitoring for Areas Affected by the Zika Virus
BusinessWire - Mon Aug 29, 7:03AM CDT
Masimo (NASDAQ: MASI) announced today that in response to the Zika virus and its potential impact on the availability of blood products, Masimo is creating a special program to dramatically reduce the cost of and increase access to Masimo's continuous hemoglobin monitoring (SpHb(R)) solutions, shown to help clinicians reduce blood transfusions in both low and high blood loss surgery. This special program will be available wherever the blood supply is affected by the Zika virus.
MASI: 59.14 (+0.15)

Bioanalytical (BASI) Launches Sampling System, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 1:10PM CDT
Bioanalytical recently introduced the 'Embrace Automation grant program' featuring 'BASi Culex NxT Automated Blood Sampling system and Raturn.'
HYH: 36.45 (unch), MASI: 59.14 (+0.15), BASI: 1.11 (unch), IDXX: 112.68 (unch)

Abaxis Hurt by Dismal Q1 Results & Fierce Competition
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:32AM CDT
Abaxis' (ABAX) first-quarter fiscal 2017 results disappointed us, with the company squarely missing the Zacks Consensus Estimate.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), ABAX: 50.14 (unch), IDXX: 112.68 (unch)

Cigna Okays 3D Mammogram: Is Hologic Poised to Gain?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 6:55AM CDT
Hologic's (HOLX) Genius 3D mammogram is the only clinically proven test to detect cancer 15 months earlier than traditional 2D screenings.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), IDXX: 112.68 (unch), HOLX: 38.42 (-0.04)

Patterson Companies (PDCO) Q1 Earnings Meet Estimates
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 2:55PM CDT
Patterson Companies reported first-quarter fiscal 2017 adjusted earnings of 51 cents per share, in line with the Zacks Consensus Estimate.
HYH: 36.45 (unch), MASI: 59.14 (+0.15), PDCO: 46.00 (unch), IDXX: 112.68 (unch)

Masimo Has Returned 49.7% Since SmarTrend Recommendation (MASI)
Comtex SmarTrend(R) - Wed Aug 24, 12:45PM CDT
SmarTrend identified an Uptrend for Masimo (NASDAQ:MASI) on February 26th, 2016 at $39.09. In approximately 6 months, Masimo has returned 49.65% as of today's recent price of $58.50.
MASI: 59.14 (+0.15)

PRA Health Sciences (PRAH) Hits 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:59AM CDT
Share price of PRA Health Sciences (PRAH) rallied to a new 52-week high of $52.72 on Aug 23, eventually closing a tad bit higher at $52.59.
MASI: 59.14 (+0.15), PRAH: 50.55 (-0.26), CRY: 15.95 (-0.11), NUVA: 65.47 (unch)

BioTelemetry Forms Partnership with Bloomlife, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:57AM CDT
BioTelemetry announced a strategic partnership with Bloom Technologies.
MASI: 59.14 (+0.15), BEAT: 18.47 (-0.51), CRY: 15.95 (-0.11), NUVA: 65.47 (unch)

5 Medical Device Stocks to Buy on Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:22AM CDT
We have picked five stocks on solid Zacks Rank.
ISRG: 686.42 (-1.11), BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), IDXX: 112.68 (unch), CRY: 15.95 (-0.11)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...